Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Mar 6:2014:595213.
doi: 10.1155/2014/595213. eCollection 2014.

Role of pentoxifylline and sparfloxacin in prophylaxis of spontaneous bacterial peritonitis in cirrhotic patients

Affiliations

Role of pentoxifylline and sparfloxacin in prophylaxis of spontaneous bacterial peritonitis in cirrhotic patients

Tarek Mohammed Mostafa et al. ISRN Gastroenterol. .

Abstract

This study was directed to evaluate the role of sparfloxacin and pentoxifylline in the prophylaxis of spontaneous bacterial peritonitis in cirrhotic patients. Forty cirrhotic patients with ascites were included in the study. Patients were randomized into four groups in a blind fashion; each group consists of ten patients. Group one received ciprofloxacin (control group), group two received sparfloxacin, group three received pentoxifylline, and group four received a combination of sparfloxacin and pentoxifylline. Treatment duration was six months. Serum TNF- α level was the primary inflammatory marker of the study to evaluate the effect of the used medications. In group two, TNF- α level showed a statistically significant decrease in comparison with group one (P = 0.001), while in group three, TNF- α level showed nonsignificant difference in comparison with the control group (P > 0.05). In addition, group four showed a statistically significant decrease in TNF- α level compared to the other three groups (P < 0.05). The finding from our study indicates that sparfloxacin as well as pentoxifylline could be used in prophylaxis of spontaneous bacterial peritonitis. Combination of sparfloxacin and pentoxifylline showed some of synergism which may be useful in decreasing emergence of resistant strains.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Changes in TNF-α level by treatment groups before treatment, three and six months after treatment. Data presented by mean ± SD. TNF-α level in the four groups decreases significantly (P < 0.5) three and six months after treatment in comparison with its level before treatment.
Figure 2
Figure 2
Changes in serum creatinine by treatment groups before treatment, three and six months after treatment. Data presented by mean ± SD. *P < 0.05 in comparison with serum creatinine before treatment.
Figure 3
Figure 3
Changes in hemoglobin concentration by treatment groups before treatment, three and six months after treatment. Data presented by mean ± SD. *P < 0.05 in comparison with hemoglobin concentration before treatment.

References

    1. Rimola A, Navasa M. Infections in liver disease. In: Bircher J, Benhamou JP, McIntyre N, Rizzetto M, Rode’s J, editors. Oxford Textbook of Clinical Hepatology. 2nd edition. Oxford, UK: Oxford University Press; 1999. pp. 1861–1876.
    1. Lata J, Stiburek O, Kopacova M. Spontaneous bacterial peritonitis: a severe complication of liver cirrhosis. World Journal of Gastroenterology. 2009;15(44):5505–5510. - PMC - PubMed
    1. Runyon BA. Spontaneous bacterial peritonitis: an explosion of information. Hepatology. 1988;8(1):171–175. - PubMed
    1. Titó L, Rimola A, Gines P, Llach J, Arroyo V, Rodes J. Recurrence of spontaneous bacterial peritonitis in cirrhosis: frequency and predictive factors. Hepatology. 1988;8(1):27–31. - PubMed
    1. Thuluvath PJ, Morss S, Thompson R. Spontaneous bacterial peritonitis—in-hospital mortality, predictors of survival, and health care costs from 1988 to 1998. The American Journal of Gastroenterology. 2001;96(4):1232–1236. - PubMed

LinkOut - more resources